While the etiology of multiple myeloma (MM) is largely unknown, evidence for an inherited genetic susceptibility is provided by the two-fold increased risk of the disease seen in first-degree relatives of cases of MM. It is likely that part of this heritable risk is a consequence of the co-inheritance of low-risk genetic variants. The accumulated experience to date in identifying risk variants for other tumors has highlighted difficulties in conducting statistically and methodologically rigorous studies. The MyelomA Genetics International Consortium (MAGIC) includes 16 research groups in Europe, Asia, Australasia, the Middle East and the Americas engaged in studying the genetics of MM. The first goal of MAGIC is to identify and characterize common genetic variants for MM through association-based analyses. Here, we review the rationale for identifying genetic risk variants for MM and our proposed strategy for establishing MAGIC.

MyelomA Genetics International Consortium / Morgan G; Johnsen HE; Goldschmidt H; Palumbo A; Cavo M; Sonneveld P; Miguel JS; Chim CS; Browne P; Einsele H; Waage A; Turesson I; Spencer A; Hajek R; Ludwig H; Hemminki K; Houlston R.. - In: LEUKEMIA & LYMPHOMA. - ISSN 1042-8194. - STAMPA. - 53:(2012), pp. 796-800. [10.3109/10428194.2011.639881]

MyelomA Genetics International Consortium.

CAVO, MICHELE;
2012

Abstract

While the etiology of multiple myeloma (MM) is largely unknown, evidence for an inherited genetic susceptibility is provided by the two-fold increased risk of the disease seen in first-degree relatives of cases of MM. It is likely that part of this heritable risk is a consequence of the co-inheritance of low-risk genetic variants. The accumulated experience to date in identifying risk variants for other tumors has highlighted difficulties in conducting statistically and methodologically rigorous studies. The MyelomA Genetics International Consortium (MAGIC) includes 16 research groups in Europe, Asia, Australasia, the Middle East and the Americas engaged in studying the genetics of MM. The first goal of MAGIC is to identify and characterize common genetic variants for MM through association-based analyses. Here, we review the rationale for identifying genetic risk variants for MM and our proposed strategy for establishing MAGIC.
2012
MyelomA Genetics International Consortium / Morgan G; Johnsen HE; Goldschmidt H; Palumbo A; Cavo M; Sonneveld P; Miguel JS; Chim CS; Browne P; Einsele H; Waage A; Turesson I; Spencer A; Hajek R; Ludwig H; Hemminki K; Houlston R.. - In: LEUKEMIA & LYMPHOMA. - ISSN 1042-8194. - STAMPA. - 53:(2012), pp. 796-800. [10.3109/10428194.2011.639881]
Morgan G; Johnsen HE; Goldschmidt H; Palumbo A; Cavo M; Sonneveld P; Miguel JS; Chim CS; Browne P; Einsele H; Waage A; Turesson I; Spencer A; Hajek R; Ludwig H; Hemminki K; Houlston R.
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/118927
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 9
  • ???jsp.display-item.citation.isi??? 6
social impact